Abbott Laboratories Stock Forecast for 2023 - 2025 - 2030

Updated on 01/31/2023

Stock Rating
10
Price Target
$125.00
Consensus
Outperform
Upside
13.07%
Analysts
15
Stock Rating
10
Upside
13.07%
Analysts
15
Price Target
$125.00

Abbott Laboratories Stock Forecast and Price Target

Abbott Laboratories's stock price reaches the average target of $125.00 by 2024 as expected recently by fiveteen notable experts, there would be a potential upside of approximately 13.07% from the last closing price in January, 2023. This possible increase is based on a high estimate of $140.00 and a low estimate of $104.00. If you are interested in ABT stock, it is important to also consider its competitors.

$125.00

13.07% Upside

Outperform
Outperform

Abbott Laboratories Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's Price has grown by 23.77%, rising from $86.02 to $106.47. For next year, analysts predict Fair Value of $132.75, which would mean an increase of 24.69%. Over the next eight years, experts predict that Abbott Laboratories's Fair Value will grow at a rate of 59.87%.

2023 Fair Value Forecast
$132.75
2024 Fair Value Forecast
$146.82
2025 Fair Value Forecast
$161.96
2026 Fair Value Forecast
$176.56
2027 Fair Value Forecast
$181.07
2028 Fair Value Forecast
$168.94
2029 Fair Value Forecast
$166.92
2030 Fair Value Forecast
$170.21
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ISRG Stock Forecast Intuitive Surgical Inc Outperform 15
$245.69 $273.80 14.78%
BSX Stock Forecast Boston Scientific Outperform 15
$46.24 $50.77 8.13%
DXCM Stock Forecast DexCom Outperform 16
$107.09 $121.12 17.19%
RMD Stock Forecast ResMed Outperform 17
$228.37 $251.67 10.57%
PODD Stock Forecast Insulet Outperform 15
$287.32 $302.13 11.37%

Abbott Laboratories Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's Revenue has grown by 135014318.25%, rising from $31.90B to $43075.00T. For the following year, the 23 analysts predict that Abbott Laboratories's Revenue will drop by 100.00%, reaching $41.39B. In 2030, the professionals' prediction is that ABT's Revenue will decrease by 100.00%, reaching $48.89B.

2023 Rev Forecast
$41.39B
2024 Rev Forecast
$44.20B
2025 Rev Forecast
$46.58B
2026 Rev Forecast
$49.65B
2027 Rev Forecast
$52.10B
2028 Rev Forecast
$49.32B
2029 Rev Forecast
$48.46B
2030 Rev Forecast
$48.89B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
NYSE:VAR Stock Forecast Varian Medical Systems - 16
$0.00 $0.00 0.00%
MASI Stock Forecast Masimo Outperform 14
$170.08 $166.14 -0.05%
SWAV Stock Forecast ShockWave Medical Outperform 4
$187.93 $0.00 -4.22%

Abbott Laboratories Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's Dividend per Share has grown, rising from $1.32 to $2.04 – a growth of 54.55%. In the following year, the 10 analysts surveyed believe that Abbott Laboratories's Dividend per Share will decrease by 3.92%, reaching $1.96. For the next eight years, the forecast is for Dividend per Share to grow by 24.75%.

2023 DPS Forecast
$1.96
2024 DPS Forecast
$2.11
2025 DPS Forecast
$2.53
2026 DPS Forecast
$2.78
2027 DPS Forecast
$2.48
2028 DPS Forecast
$2.37
2029 DPS Forecast
$2.43
2030 DPS Forecast
$2.54
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
LVGO Stock Forecast Livongo Health - 0
$0.00 $0.00 0.00%
INSP Stock Forecast Inspire Medical Systems Outperform 6
$253.06 $0.00 18.55%
CMD Stock Forecast Cantel Medical - 17
$0.09 $85.00 155222.22%

Abbott Laboratories Free Cash Flow Forecast for 2023 - 2025 - 2030

Abbott Laboratories's Free Cash Flow has seen impressive growth In the last three years, rising from $4.50B to $11698.00T – a growth of 260071000.82%. According to the 6 analysts polled, in the next year, Abbott Laboratories's Free Cash Flow will fall by 100.00%, reaching $8.56B. By 2030, professionals believe that Abbott Laboratories's Free Cash Flow will have decreased by 100.00%, falling to $10.97B.

2023 FCF Forecast
$8.56B
2024 FCF Forecast
$9.04B
2025 FCF Forecast
$9.48B
2026 FCF Forecast
$9.58B
2027 FCF Forecast
$13.70B
2028 FCF Forecast
$12.07B
2029 FCF Forecast
$11.36B
2030 FCF Forecast
$10.97B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
AXNX Stock Forecast Axonics Buy 7
$62.69 $0.00 14.85%
IRTC Stock Forecast iRhythm Technologies Hold 11
$98.30 $0.00 56.66%
CNMD Stock Forecast CONMED Outperform 16
$95.76 $145.00 25.31%

Abbott Laboratories Net Income Forecast for 2023 - 2025 - 2030

Abbott Laboratories's Net Income has grown In the last three years, rising from $3.69B to $7071.00T – a growth of 191781836.53%. The next year, 19 experts forecast that Abbott Laboratories's Net Income will decrease by 100.00%, reaching $8.79B. In 2030, professionals predict that Abbott Laboratories's Net Income will decrease by 100.00%, reaching $11.30B.

2023 NI Forecast
$8.79B
2024 NI Forecast
$9.75B
2025 NI Forecast
$10.69B
2026 NI Forecast
$11.74B
2027 NI Forecast
$12.03B
2028 NI Forecast
$11.22B
2029 NI Forecast
$11.07B
2030 NI Forecast
$11.30B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
TNDM Stock Forecast Tandem Diabetes Care Outperform 9
$40.74 $127.93 125.82%
ITGR Stock Forecast Integer Holdings Buy 16
$65.81 $111.33 65.63%
GNMK Stock Forecast GenMark Diagnostics - 2
$0.00 $24.05 0.00%

Abbott Laboratories EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's EBITDA has grown by 158061925.48%, rising from $7.77B to $12283.00T. For the next year, 11 analysts project Abbott Laboratories's EBITDA to drop by 100.00%, reaching $11.94B. By 2030, professionals believe that Abbott Laboratories's EBITDA will decrease by 100.00%, reaching $13.04B – a concerning trend for the company.

2023 EBITDA Forecast
$11.94B
2024 EBITDA Forecast
$13.15B
2025 EBITDA Forecast
$12.29B
2026 EBITDA Forecast
$13.49B
2027 EBITDA Forecast
$12.99B
2028 EBITDA Forecast
$13.07B
2029 EBITDA Forecast
$12.83B
2030 EBITDA Forecast
$13.04B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
NVRO Stock Forecast Nevro Hold 6
$36.72 $69.50 75.65%
SILK Stock Forecast Silk Road Medical, Inc Outperform 7
$54.36 $0.00 -4.34%
TMDX Stock Forecast TransMedics Group Outperform 8
$63.02 $0.00 -55.57%

Abbott Laboratories EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Abbott Laboratories's EBIT has grown, moving from $4.76B to $9.22B – an increase of 93.78%. In the next year, analysts predict that EBIT will jump to $10.32B – up 11.95% from the current level. Looking ahead to eight years, experts forecast that EBIT will grow by 43.17%.

2023 EBIT Forecast
$10.32B
2024 EBIT Forecast
$11.31B
2025 EBIT Forecast
$12.07B
2026 EBIT Forecast
$13.81B
2027 EBIT Forecast
$14.30B
2028 EBIT Forecast
$13.23B
2029 EBIT Forecast
$12.88B
2030 EBIT Forecast
$13.20B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
NTUS Stock Forecast Natus Medical - 14
$32.96 $36.00 70.27%
CUTR Stock Forecast Cutera Buy 6
$34.83 $42.20 123.94%
SENS Stock Forecast Senseonics Holdings Hold 6
$1.13 $0.00 121.24%

Abbott Laboratories EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's EPS has grown by 23.77%, rising from $3.24 to $4.01. For next year, analysts predict EPS of $5.00, which would mean an increase of 24.69%. Over the next eight years, experts predict that Abbott Laboratories's EPS will grow at a rate of 59.87%.

2023 EPS Forecast
$5.00
2024 EPS Forecast
$5.53
2025 EPS Forecast
$6.10
2026 EPS Forecast
$6.65
2027 EPS Forecast
$6.82
2028 EPS Forecast
$6.36
2029 EPS Forecast
$6.29
2030 EPS Forecast
$6.41
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
INGN Stock Forecast Inogen Outperform 8
$22.45 $44.00 42.54%
QTRX Stock Forecast Quanterix Buy 11
$13.88 $0.00 162.97%
VRAY Stock Forecast ViewRay Outperform 7
$4.42 $0.00 92.31%